Dobromir Petkov Dobrev

Dobromir Petkov Dobrev's AcademicInfluence.com Rankings

Medical

#2168

World Rank

#2572

Historical Rank

Surgery

#173

World Rank

#221

Historical Rank

medical Degrees

Download Badge

Medical

Dobromir Petkov Dobrev's Degrees

PhD Cardiovascular Surgery University of Zurich

Why Is Dobromir Petkov Dobrev Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Dobromir Petkov Dobrev's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

ESC / EACTS Guidelines on myocardial revascularization (2012) (5643)
2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS. (2016) (4929)
2014 ESC/EACTS Guidelines on myocardial revascularization: the Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). Developed with the special contribution of the European Association of Percutaneous (2014) (3302)
2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS. (2016) (2451)
Atrial Remodeling and Atrial Fibrillation: Mechanisms and Implications (2008) (942)
The clinical profile and pathophysiology of atrial fibrillation: relationships among clinical features, epidemiology, and mechanisms. (2014) (810)
Recent advances in the molecular pathophysiology of atrial fibrillation. (2011) (511)
Enhanced Sarcoplasmic Reticulum Ca2+ Leak and Increased Na+-Ca2+ Exchanger Function Underlie Delayed Afterdepolarizations in Patients With Chronic Atrial Fibrillation (2012) (502)
EHRA/HRS/APHRS/SOLAECE expert consensus on atrial cardiomyopathies: definition, characterization, and clinical implication. (2016) (478)
Cellular and Molecular Electrophysiology of Atrial Fibrillation Initiation, Maintenance, and Progression (2014) (478)
The G Protein–Gated Potassium Current IK,ACh Is Constitutively Active in Patients With Chronic Atrial Fibrillation (2005) (435)
Calmodulin kinase II-mediated sarcoplasmic reticulum Ca2+ leak promotes atrial fibrillation in mice. (2009) (385)
Cellular and Molecular Mechanisms of Atrial Arrhythmogenesis in Patients With Paroxysmal Atrial Fibrillation (2014) (362)
Defective Cardiac Ryanodine Receptor Regulation During Atrial Fibrillation (2005) (338)
Molecular Basis of Downregulation of G-Protein–Coupled Inward Rectifying K+ Current (IK,ACh) in Chronic Human Atrial Fibrillation: Decrease in GIRK4 mRNA Correlates With Reduced IK,ACh and Muscarinic Receptor–Mediated Shortening of Action Potentials (2001) (331)
Human Atrial Action Potential and Ca2+ Model: Sinus Rhythm and Chronic Atrial Fibrillation (2011) (325)
Calcium Signaling and Cardiac Arrhythmias. (2017) (291)
L-Type Ca2+ Current Downregulation in Chronic Human Atrial Fibrillation Is Associated With Increased Activity of Protein Phosphatases (2004) (285)
Enhanced Cardiomyocyte NLRP3 Inflammasome Signaling Promotes Atrial Fibrillation (2018) (273)
Molecular Determinants of Altered Ca2+ Handling in Human Chronic Atrial Fibrillation (2006) (268)
Role of IKur in Controlling Action Potential Shape and Contractility in the Human Atrium: Influence of Chronic Atrial Fibrillation (2004) (259)
Calcium-Handling Abnormalities Underlying Atrial Arrhythmogenesis and Contractile Dysfunction in Dogs With Congestive Heart Failure (2008) (257)
Atrial fibrillation promotion by endurance exercise: demonstration and mechanistic exploration in an animal model. (2013) (247)
Human Atrial Ion Channel and Transporter Subunit Gene-Expression Remodeling Associated With Valvular Heart Disease and Atrial Fibrillation (2005) (241)
Comprehensive risk reduction in patients with atrial fibrillation: emerging diagnostic and therapeutic options--a report from the 3rd Atrial Fibrillation Competence NETwork/European Heart Rhythm Association consensus conference. (2012) (241)
Oxidized Ca2+/Calmodulin-Dependent Protein Kinase II Triggers Atrial Fibrillation (2013) (239)
EHRA/HRS/APHRS/SOLAECE expert consensus on atrial cardiomyopathies: Definition, characterization, and clinical implication. (2016) (229)
Transient Receptor Potential Canonical-3 Channel–Dependent Fibroblast Regulation in Atrial Fibrillation (2012) (223)
MicroRNA29: A Mechanistic Contributor and Potential Biomarker in Atrial Fibrillation (2013) (220)
Left-to-Right Atrial Inward Rectifier Potassium Current Gradients in Patients With Paroxysmal Versus Chronic Atrial Fibrillation (2010) (206)
Postoperative atrial fibrillation: mechanisms, manifestations and management (2019) (204)
Oxidized CaMKII causes cardiac sinus node dysfunction in mice. (2011) (203)
Role of RyR2 Phosphorylation at S2814 During Heart Failure Progression (2012) (198)
Cellular Signaling Underlying Atrial Tachycardia Remodeling of L-type Calcium Current (2008) (190)
Novel molecular targets for atrial fibrillation therapy (2012) (188)
Remodeling of cardiomyocyte ion channels in human atrial fibrillation (2003) (187)
The multidimensional role of calcium in atrial fibrillation pathophysiology: mechanistic insights and therapeutic opportunities. (2012) (186)
Electrical Remodeling in Atrial Fibrillation (2006) (165)
Role of Small-Conductance Calcium-Activated Potassium Channels in Atrial Electrophysiology and Fibrillation in the Dog (2014) (159)
Decreased phosphorylation levels of cardiac myosin-binding protein-C in human and experimental heart failure. (2007) (158)
The value of basic research insights into atrial fibrillation mechanisms as a guide to therapeutic innovation: a critical analysis. (2016) (155)
Mutation E169K in junctophilin-2 causes atrial fibrillation due to impaired RyR2 stabilization. (2013) (154)
Molecular Basis of Atrial Fibrillation Pathophysiology and Therapy (2020) (151)
Human inward rectifier potassium channels in chronic and postoperative atrial fibrillation. (2002) (147)
Ryanodine Receptor–Mediated Calcium Leak Drives Progressive Development of an Atrial Fibrillation Substrate in a Transgenic Mouse Model (2014) (142)
Transverse tubules are a common feature in large mammalian atrial myocytes including human. (2011) (140)
Personalized management of atrial fibrillation: Proceedings from the fourth Atrial Fibrillation competence NETwork/European Heart Rhythm Association consensus conference. (2013) (140)
A roadmap to improve the quality of atrial fibrillation management: proceedings from the fifth Atrial Fibrillation Network/European Heart Rhythm Association consensus conference. (2016) (137)
Inhibition of CaMKII Phosphorylation of RyR2 Prevents Induction of Atrial Fibrillation in FKBP12.6 Knockout Mice (2012) (134)
Animal models for atrial fibrillation: clinical insights and scientific opportunities. (2010) (131)
Role of RyR2 Phosphorylation in Heart Failure and Arrhythmias: Controversies Around Ryanodine Receptor Phosphorylation in Cardiac Disease (2014) (130)
Mechanisms of Atrial Tachyarrhythmias Associated With Coronary Artery Occlusion in a Chronic Canine Model (2011) (126)
Upregulation of K2P3.1 K+ Current Causes Action Potential Shortening in Patients With Chronic Atrial Fibrillation (2015) (124)
Acute atrial tachyarrhythmia induces angiotensin II type 1 receptor-mediated oxidative stress and microvascular flow abnormalities in the ventricles (2009) (124)
New antiarrhythmic drugs for treatment of atrial fibrillation (2010) (124)
Intracellular calcium leak due to FKBP12.6 deficiency in mice facilitates the inducibility of atrial fibrillation. (2008) (124)
Differential phosphorylation-dependent regulation of constitutively active and muscarinic receptor-activated IK,ACh channels in patients with chronic atrial fibrillation. (2007) (122)
Cardiac CaM Kinase II Genes &dgr; and &ggr; Contribute to Adverse Remodeling but Redundantly Inhibit Calcineurin-Induced Myocardial Hypertrophy (2014) (119)
Autoantibodies against the beta1 adrenoceptor from patients with dilated cardiomyopathy prolong action potential duration and enhance contractility in isolated cardiomyocytes. (2001) (118)
Calcium Handling Abnormalities in Atrial Fibrillation as a Target for Innovative Therapeutics (2008) (118)
Phosphodiesterase-2 is up-regulated in human failing hearts and blunts β-adrenergic responses in cardiomyocytes. (2013) (116)
Electrophysiological and molecular mechanisms of paroxysmal atrial fibrillation (2016) (115)
Defects in Ankyrin-Based Membrane Protein Targeting Pathways Underlie Atrial Fibrillation (2011) (115)
Translational Challenges in Atrial Fibrillation (2018) (113)
MicroRNA Regulation and Cardiac Calcium Signaling: Role in Cardiac Disease and Therapeutic Potential (2014) (113)
The ryanodine receptor channel as a molecular motif in atrial fibrillation: pathophysiological and therapeutic implications. (2011) (111)
Multiple Potential Molecular Contributors to Atrial Hypocontractility Caused by Atrial Tachycardia Remodeling in Dogs (2010) (111)
Pathology‐specific effects of the IKur/Ito/IK,ACh blocker AVE0118 on ion channels in human chronic atrial fibrillation (2008) (110)
G-Protein beta(3)-subunit 825T allele is associated with enhanced human atrial inward rectifier potassium currents. (2000) (109)
Remodelling of cardiac repolarization: how homeostatic responses can lead to arrhythmogenesis. (2008) (106)
Phosphatase inhibitor-1-deficient mice are protected from catecholamine-induced arrhythmias and myocardial hypertrophy. (2008) (105)
Vascular large conductance calcium-activated potassium channels: Functional role and therapeutic potential (2007) (103)
Function and regulation of serine/threonine phosphatases in the healthy and diseased heart. (2013) (102)
Tachycardia-induced silencing of subcellular Ca2+ signaling in atrial myocytes. (2014) (102)
Differential Protein Kinase C Isoform Regulation and Increased Constitutive Activity of Acetylcholine-Regulated Potassium Channels in Atrial Remodeling (2011) (101)
Distinct contractile and molecular differences between two goat models of atrial dysfunction: AV block-induced atrial dilatation and atrial fibrillation. (2009) (100)
Atrial Myocyte NLRP3/CaMKII Nexus Forms a Substrate for Postoperative Atrial Fibrillation (2020) (98)
Comparing the global mRNA expression profile of human atrial and ventricular myocardium with high-density oligonucleotide arrays. (2005) (98)
Loss of MicroRNA-106b-25 Cluster Promotes Atrial Fibrillation by Enhancing Ryanodine Receptor Type-2 Expression and Calcium Release (2014) (98)
Changes in I K, ACh single-channel activity with atrial tachycardia remodelling in canine atrial cardiomyocytes. (2008) (97)
Evidence for Edg-3 receptor-mediated activation of I(K.ACh) by sphingosine-1-phosphate in human atrial cardiomyocytes. (2000) (96)
COVID-19 associated atrial fibrillation: Incidence, putative mechanisms and potential clinical implications (2020) (96)
Integrating new approaches to atrial fibrillation management: the 6th AFNET/EHRA Consensus Conference (2018) (94)
Role of autonomic nervous system in atrial fibrillation. (2019) (94)
Constitutively active phosphatase inhibitor-1 improves cardiac contractility in young mice but is deleterious after catecholaminergic stress and with aging. (2010) (91)
The Cardiac CaMKII Genes δ and γ Contribute Redundantly to Adverse Remodeling but Inhibit Calcineurin-Induced Myocardial Hypertrophy (2014) (90)
EHRA/HRS/APHRS/SOLAECE expert consensus on Atrial cardiomyopathies: Definition, characterisation, and clinical implication☆☆☆ (2016) (86)
Pharmacological evidence for altered src kinase regulation of ICa,L in patients with chronic atrial fibrillation (2007) (84)
Role of inflammatory signaling in atrial fibrillation. (2019) (80)
Fibroblast inward-rectifier potassium current upregulation in profibrillatory atrial remodeling. (2015) (80)
Current controversies in determining the main mechanisms of atrial fibrillation (2016) (76)
Potassium currents in the heart: functional roles in repolarization, arrhythmia and therapeutics (2017) (74)
Atrial Fibrillation Activates AMP-Dependent Protein Kinase and its Regulation of Cellular Calcium Handling: Potential Role in Metabolic Adaptation and Prevention of Progression. (2015) (74)
Inverse remodelling of K2P3.1 K+ channel expression and action potential duration in left ventricular dysfunction and atrial fibrillation: implications for patient-specific antiarrhythmic drug therapy (2017) (73)
The impact of rapid atrial pacing on ADMA and endothelial NOS. (2012) (69)
NSC23766, a Widely Used Inhibitor of Rac1 Activation, Additionally Acts as a Competitive Antagonist at Muscarinic Acetylcholine Receptors (2013) (68)
Profibrotic, Electrical, and Calcium-Handling Remodeling of the Atria in Heart Failure Patients With and Without Atrial Fibrillation (2018) (66)
An update on atrial fibrillation in 2014: From pathophysiology to treatment. (2016) (62)
Role of calcineurin and protein phosphatase-2A in the regulation of phosphatase inhibitor-1 in cardiac myocytes. (2006) (62)
Controversies About Atrial Fibrillation Mechanisms: Aiming for Order in Chaos and Whether it Matters (2017) (60)
Calcium dysregulation in atrial fibrillation: the role of CaMKII (2014) (59)
Cardiomyocyte calcium handling in health and disease: Insights from in vitro and in silico studies. (2020) (57)
Ca2+-Related Signaling and Protein Phosphorylation Abnormalities Play Central Roles in a New Experimental Model of Electrical Storm (2011) (57)
Impaired local regulation of ryanodine receptor type 2 by protein phosphatase 1 promotes atrial fibrillation. (2013) (56)
Palmitoylation and Membrane Association of the Stress Axis Regulated Insert (STREX) Controls BK Channel Regulation by Protein Kinase C* (2012) (55)
Inhibition of IK,ACh current may contribute to clinical efficacy of class I and class III antiarrhythmic drugs in patients with atrial fibrillation (2010) (53)
Dysfunction in the &bgr;II Spectrin–Dependent Cytoskeleton Underlies Human Arrhythmia (2015) (52)
New directions in antiarrhythmic drug therapy for atrial fibrillation. (2013) (50)
NLRP3 inflammasome is a key driver of Obesity-Induced atrial arrhythmias. (2021) (48)
Calcium‐mediated cellular triggered activity in atrial fibrillation (2017) (48)
Antiarrhythmic drugs for atrial fibrillation: Imminent impulses are emerging (2018) (47)
Two-electrode telemetric instrument for infant heart rate and apnea monitoring. (1999) (47)
Identification of MicroRNA‐mRNA Dysregulations in Paroxysmal Atrial Fibrillation (2015) (47)
Detailed characterization of microRNA changes in a canine heart failure model: Relationship to arrhythmogenic structural remodeling. (2014) (46)
The effects of verapamil and diltiazem on N‐, P‐ and Q‐type calcium channels mediating dopamine release in rat striatum (1999) (46)
Phosphatase-1 inhibitor-1 in physiological and pathological β-adrenoceptor signalling. (2011) (45)
JAK-STAT signalling and the atrial fibrillation promoting fibrotic substrate (2017) (44)
Computational models of atrial cellular electrophysiology and calcium handling, and their role in atrial fibrillation (2016) (44)
Cardiomyocyte Inflammasome Signaling in Cardiomyopathies and Atrial Fibrillation: Mechanisms and Potential Therapeutic Implications (2018) (44)
Cardiac safety assays. (2014) (44)
Teaching antiarrhythmic therapy and ECG in simulator-based interdisciplinary undergraduate medical education. (2005) (44)
Atrial Ca2+ signaling in atrial fibrillation as an antiarrhythmic drug target (2010) (43)
Decreased ATP-sensitive K(+) current density during chronic human atrial fibrillation. (2003) (41)
Loss of Protein Phosphatase 1 Regulatory Subunit PPP1R3A Promotes Atrial Fibrillation. (2019) (40)
Impaired Na⁺-dependent regulation of acetylcholine-activated inward-rectifier K⁺ current modulates action potential rate dependence in patients with chronic atrial fibrillation. (2013) (40)
Thrombin receptor PAR4 drives canonical NLRP3 inflammasome signaling in the heart (2020) (40)
Calmodulin kinase II, sarcoplasmic reticulum Ca2+ leak, and atrial fibrillation. (2010) (39)
Alterations in the interactome of serine/threonine protein phosphatase type-1 in atrial fibrillation patients. (2015) (38)
Role of I Kur in Controlling Action Potential Shape and Contractility in the Human Atrium Influence of Chronic Atrial Fibrillation (2004) (36)
Differences in Left Versus Right Ventricular Electrophysiological Properties in Cardiac Dysfunction and Arrhythmogenesis. (2016) (36)
Loss of SPEG Inhibitory Phosphorylation of Ryanodine Receptor Type-2 Promotes Atrial Fibrillation (2020) (36)
Nightly sleep apnea severity in patients with atrial fibrillation: Potential applications of long-term sleep apnea monitoring (2019) (36)
Counteracting Protein Kinase Activity in the Heart: The Multiple Roles of Protein Phosphatases (2015) (35)
EHRA White Paper: knowledge gaps in arrhythmia management-status 2019. (2019) (34)
Amiodarone causes endothelium‐dependent vasodilation in human hand veins in vivo * (1998) (33)
Investigational antiarrhythmic agents: promising drugs in early clinical development (2017) (33)
Aldosterone‐receptor antagonism as a potential therapeutic option for atrial fibrillation (2010) (32)
Identification of optimal reference genes for transcriptomic analyses in normal and diseased human heart (2018) (32)
Electrical storm: recent pathophysiological insights and therapeutic consequences (2013) (31)
Expression and function of Kv1.1 potassium channels in human atria from patients with atrial fibrillation (2015) (31)
Atrial-Selective Potassium Channel Blockers. (2016) (30)
Enhanced myofilament responsiveness upon β-adrenergic stimulation in post-infarct remodeled myocardium. (2011) (30)
Differential regulation of protein phosphatase 1 (PP1) isoforms in human heart failure and atrial fibrillation (2017) (29)
Dynamic risk assessment to improve quality of care in patients with atrial fibrillation: the 7th AFNET/EHRA Consensus Conference. (2020) (29)
Constitutive activity of the acetylcholine-activated potassium current IK,ACh in cardiomyocytes. (2014) (29)
On‐demand mobile health infrastructures to allow comprehensive remote atrial fibrillation and risk factor management through teleconsultation (2020) (29)
The role of amiodarone in contemporary management of complex cardiac arrhythmias. (2019) (28)
S‐glutathiolation impairs phosphoregulation and function of cardiac myosin‐binding protein C in human heart failure (2016) (28)
New insights into the molecular basis of atrial fibrillation: mechanistic and therapeutic implications. (2011) (28)
Ascorbic Acid–Induced Modulation of Venous Tone in Humans (2001) (28)
Mouse Models of Cardiac Arrhythmias. (2018) (27)
Upregulation of K 2 P 3 . 1 K + Current Causes Action Potential Shortening in Patients With Chronic Atrial Fibrillation (2015) (27)
Calcium handling and atrial fibrillation (2012) (26)
Two-electrode biopotential amplifier with current-driven inputs (2006) (26)
Serine/Threonine Phosphatases in Atrial Fibrillation. (2017) (26)
Gut microbiota, dysbiosis and atrial fibrillation. Arrhythmogenic mechanisms and potential clinical implications. (2021) (26)
Regulating the regulator: Insights into the cardiac protein phosphatase 1 interactome. (2016) (25)
Isolation of human atrial myocytes for simultaneous measurements of Ca2+ transients and membrane currents. (2013) (25)
Interference with ERK-dimerization at the nucleocytosolic interface targets pathological ERK1/2 signaling without cardiotoxic side-effects (2020) (25)
Unique atrial myocyte Ca2+ signaling. (2009) (25)
Voltage-clamp-based methods for the detection of constitutively active acetylcholine-gated I(K,ACh) channels in the diseased heart. (2010) (25)
Acute effects of alcohol on cardiac electrophysiology and arrhythmogenesis: Insights from multiscale in silico analyses. (2020) (25)
Methods for isolating atrial cells from large mammals and humans. (2015) (24)
Application of the RIMARC algorithm to a large data set of action potentials and clinical parameters for risk prediction of atrial fibrillation (2015) (24)
Altered calcium-handling produces reentry-promoting action potential alternans in atrial fibrillation-remodeled hearts. (2020) (24)
Local venous response to N‐desethylamiodarone in humans (2000) (23)
Mechanisms of β‐adrenergic Receptor–mediated Venodilation in Humans (2004) (23)
Pleiotropic Effects of Antiarrhythmic Agents: Dronedarone in the Treatment of Atrial Fibrillation (2013) (22)
Why translation from basic discoveries to clinical applications is so difficult for atrial fibrillation and possible approaches to improving it. (2021) (22)
In Silico Assessment of Efficacy and Safety of IKur Inhibitors in Chronic Atrial Fibrillation: Role of Kinetics and State-Dependence of Drug Binding (2017) (22)
Digital lock-in techniques for adaptive power-line interference extraction (2008) (21)
Regulation of sarcoplasmic reticulum Ca(2+)-ATPase and phospholamban in the failing and nonfailing heart. (2000) (20)
T-Type Calcium Current Contributes to Escape Automaticity and Governs the Occurrence of Lethal Arrhythmias After Atrioventricular Block in Mice (2013) (20)
The inward rectifier current inhibitor PA‐6 terminates atrial fibrillation and does not cause ventricular arrhythmias in goat and dog models (2017) (20)
Nucleoside Diphosphate Kinase-C Suppresses cAMP Formation in Human Heart Failure (2017) (20)
Dysfunction of the β2-spectrin-based pathway in human heart failure. (2016) (20)
Reproducibility of Dorsal Hand Vein Responses to Phenylephrine and Prostaglandin F2α Using the Dorsal Hand Vein Compliance Method (2003) (20)
Simple two-electrode biosignal amplifier (2005) (20)
Role of T-type calcium channel subunits in post-myocardial infarction remodelling probed with genetically engineered mice. (2011) (19)
Atrial arrhythmogenesis in catecholaminergic polymorphic ventricular tachycardia – is there a mechanistic link between sarcoplasmic reticulum Ca2+ leak and re‐entry? (2013) (19)
Heterogeneity in hand veins responses to acetylcholine is not associated with polymorphisms in the G-protein beta3-subunit (C825T) and endothelial nitric oxide synthase (G894T) genes but with serum low density lipoprotein cholesterol. (2001) (19)
Ion Channel Remodelling in Atrial Fibrillation (2010) (18)
Calcium Handling Abnormalities as a Target for Atrial Fibrillation Therapeutics: How Close to Clinical Implementation? (2015) (18)
Angiotensin Receptor-Neprilysin Inhibitor (ARNI) and Cardiac Arrhythmias (2021) (18)
Computational modeling: What does it tell us about atrial fibrillation therapy? (2019) (18)
Safety and efficacy of vernakalant for acute cardioversion of atrial fibrillation: an update (2013) (18)
Altered Atrial Metabolism: An Underappreciated Contributor to the Initiation and Progression of Atrial Fibrillation (2015) (18)
Revealing kinetics and state-dependent binding properties of IKur-targeting drugs that maximize atrial fibrillation selectivity. (2017) (18)
N-desethylamiodarone modulates intracellular calcium concentration in endothelial cells (2000) (17)
Restriction and functional changes of dopamine release in rat striatum from young adult and old rats (1995) (17)
Maastricht antiarrhythmic drug evaluator (MANTA): a computational tool for better understanding of antiarrhythmic drugs. (2019) (17)
PITX2: a master regulator of cardiac channelopathy in atrial fibrillation? (2016) (17)
What is a good tutorial from the student's point of view? Evaluation of tutorials in a newly established PBL block course "Basics of Drug Therapy (2002) (16)
Loss of Cardiomyocyte Integrin-Linked Kinase Produces an Arrhythmogenic Cardiomyopathy in Mice (2015) (16)
Muscarinic type-1 receptors contribute to IK,ACh in human atrial cardiomyocytes and are upregulated in patients with chronic atrial fibrillation. (2017) (16)
The combined effects of ranolazine and dronedarone on human atrial and ventricular electrophysiology. (2016) (16)
Irregular rhythm and atrial metabolism are key for the evolution of proarrhythmic atrial remodeling in atrial fibrillation (2015) (16)
Does gut microbiota affect atrial rhythm? Causalities and speculations. (2021) (15)
Quantification of G protein Gaalphas subunit splice variants in different human tissues and cells using pyrosequencing. (2005) (15)
Ablation of the calpain-targeted site in cardiac myosin binding protein-C is cardioprotective during ischemia-reperfusion injury. (2019) (15)
No evidence for an association between the rs2824292 variant at chromosome 21q21 and ventricular fibrillation during acute myocardial infarction in a German population (2011) (15)
Inhibition of Small-Conductance Ca2+-Activated K+ Channels: The Long-Awaited Breakthrough for Antiarrhythmic Drug Therapy of Atrial Fibrillation? (2017) (15)
Bootstrapped two-electrode biosignal amplifier (2008) (15)
Acute hemodynamic effects during immunoadsorption in patients with dilated cardiomyopathy positive for beta 1-adrenoceptor autoantibodies. (2001) (15)
Cardiac sympathetic innervation and control of potassium channel function. (2003) (14)
Cellular and molecular correlates of ectopic activity in patients with atrial fibrillation. (2012) (14)
Straight to the heart: Pleiotropic antiarrhythmic actions of oral anticoagulants. (2019) (14)
Abstract 2630: Cellular and Molecular Determinants of Altered Atrial Ca2+ Signaling in Patients With Chronic Atrial Fibrillation (2009) (14)
Proarrhythmic atrial calcium cycling in the diseased heart. (2012) (14)
CaMKII activity contributes to homeometric autoregulation of the heart: A novel mechanism for the Anrep effect (2020) (14)
Nucleoside Diphosphate Kinase B–Activated Intermediate Conductance Potassium Channels Are Critical for Neointima Formation in Mouse Carotid Arteries (2015) (13)
Non-ion channel therapeutics for heart failure and atrial fibrillation: Are CaMKII inhibitors ready for clinical use? (2018) (13)
Is altered atrial microRNA-ome a critical contributor to the pathophysiology of atrial fibrillation? (2012) (13)
The German Competence Network on Atrial Fibrillation (AFNET) (2008) (13)
Novel anti-arrhythmic agents for the treatment of atrial fibrillation. (2007) (12)
SPEG: a key regulator of cardiac calcium homeostasis. (2020) (12)
Cardiomyocyte Ca2+ overload in atrial tachycardia: is blockade of L-type Ca2+ channels a promising approach to prevent electrical remodeling and arrhythmogenesis? (2007) (12)
Inositol Trisphosphate Receptors and Nuclear Calcium in Atrial Fibrillation. (2020) (12)
Inflammatory signalling in atrial cardiomyocytes: a novel unifying principle in atrial fibrillation pathophysiology (2022) (12)
2016 ESC guidelines for the diagnosis and treatment of atrial fibrillation developed in collaboration with the EACTS (2017) (11)
Hyperuricemia: A causal player or a bystander linking inflammatory signaling and atrial fibrillation? (2017) (11)
Rhythm control of atrial fibrillation in heart failure. (2013) (11)
Chronic loss of inhibitor-1 diminishes cardiac RyR2 phosphorylation despite exaggerated CaMKII activity (2017) (11)
Therapeutically relevant concentrations of neomycin selectively inhibit P-type Ca2+ channels in rat striatum. (2003) (11)
Voltage-activated calcium channels involved in veratridine-evoked [3H]dopamine release in rat striatal slices (1998) (11)
Ectopic expression of S28A-mutated Histone H3 modulates longevity, stress resistance and cardiac function in Drosophila (2018) (11)
Diminished PLK2 Induces Cardiac Fibrosis and Promotes Atrial Fibrillation (2021) (11)
Mechanisms of beta-adrenergic receptor-mediated venodilation in humans. (2004) (11)
Functional identification of M1 and M3 muscarinic acetylcholine receptors in human atrial myocytes Influence of chronic atrial fibrillation (2002) (10)
Muscarinic subtype-2 receptor autoantibodies: actors or bystanders in human atrial fibrillation? (2004) (10)
Pleiotropic actions of amiodarone: still puzzling after half a century (2013) (10)
Emerging Antiarrhythmic Drugs for Atrial Fibrillation (2022) (10)
ESC working group on cardiac cellular electrophysiology position paper: relevance, opportunities, and limitations of experimental models for cardiac electrophysiology research. (2021) (10)
Sleep-Disordered Breathing and Cardiac Arrhythmias in Adults: Mechanistic Insights and Clinical Implications: A Scientific Statement From the American Heart Association. (2022) (10)
Regulation of heterotrimeric G-protein signaling by NDPK/NME proteins and caveolins: an update (2018) (10)
Ion channel portrait of the human sinus node: useful for a better understanding of sinus node function and dysfunction in humans? (2009) (9)
Effects of immunoglobulin G from patients with dilated cardiomyopathy on rat cardiomyocytes. (2005) (9)
Searching for atrial fibrillation: looking harder, looking longer, and in increasingly sophisticated ways. An EHRA position paper'. (2022) (8)
[New antiarrhythmic drugs for therapy of atrial fibrillation: II. Non-ion channel blockers]. (2006) (8)
Systems approaches to post-operative atrial fibrillation - do they help us to better understand the ionic basis of the arrhythmogenic substrate? (2012) (8)
The European Network for Translational Research in Atrial Fibrillation (EUTRAF): objectives and initial results. (2012) (8)
Arrhythmia / Electrophysiology Enhanced Sarcoplasmic Reticulum Ca 2 Leak and Increased Na-Ca 2 Exchanger Function Underlie Delayed Afterdepolarizations in Patients With Chronic Atrial Fibrillation (2012) (8)
Cellular Mechanisms of the Anti-Arrhythmic Effect of Cardiac PDE2 Overexpression (2021) (8)
An aqueous extract of the marine sponge Ectyoplasia ferox stimulates L-type Ca2+-current by direct interaction with the Cav1.2 subunit (2004) (8)
Modulation of Potassium-Evoked [3H]Dopamine Release from Rat Striatal Slices by Voltage-Activated Calcium Channel Ligands: Effects of ω-Conotoxin-MVIIC (1997) (8)
The crosstalk between cardiomyocyte calcium and inflammasome signaling pathways in atrial fibrillation (2021) (7)
Deciphering the fundamental mechanisms of atrial fibrillation: a quest for over a century. (2016) (7)
Conditional immortalization of human atrial myocytes for the generation of in vitro models of atrial fibrillation (2022) (7)
Atrial-selective sodium channel block by dronedarone: sufficient to terminate atrial fibrillation? (2011) (7)
Bound to bleed: How altered albumin binding may dictate warfarin treatment outcome (2019) (7)
Resveratrol: an effective pharmacological agent to prevent inflammation-induced atrial fibrillation? (2018) (7)
Atrial disease and heart failure: the common soil hypothesis proposed by the Heart Failure Association of the European Society of Cardiology. (2021) (7)
Ion channels as part of macromolecular multiprotein complexes (2017) (7)
Adiposity-associated atrial fibrillation: molecular determinants, mechanisms and clinical significance. (2022) (7)
Mapping genetic changes in the cAMP-signaling cascade in human atria. (2021) (7)
Sinus Rhythm and Chronic Atrial Fibrillation (2011) (7)
Four and a half LIM protein 1: a novel chaperone for atrium-specific Kv1.5 channels with a potential role in atrial arrhythmogenesis. (2008) (7)
Oxidative stress: a baystander or a causal contributor to atrial remodeling and fibrillation? (2021) (6)
Current Driven Automatic Electrode Impedance Balance for Ground-free Biosignal Acquisition (2014) (6)
Software PLL for Power-line Interference Synchronization: Implementation and Results (2015) (6)
Double Jeopardy: Will the new trials tell us how to manage patients with atrial fibrillation and coronary artery disease? (2019) (6)
42 – The Molecular Pathophysiology of Atrial Fibrillation (2018) (6)
NSC 23766 , a Widely Used Inhibitor of Rac 1 Activation , Additionally Acts as a Competitive Antagonist at Muscarinic Acetylcholine Receptors s (2013) (6)
One ring to rule them all: Continuous monitoring of patients with secondary atrial fibrillation points to a unifying underlying mechanism. (2021) (6)
Facing the challenge of polypharmacy when prescribing for older people with cardiovascular disease. A review by the European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy. (2022) (6)
Conventional Troponin-I versus high-sensitivity troponin-T: Performance and incremental prognostic value in non-ST-elevation acute myocardial infarction patients with negative CK-MB based on a real-world multicenter cohort (2018) (6)
Software PLL for Power-line Interference Synchronization: Design, Modeling and Simulation (2014) (5)
Interaction of Cardiovascular Nonmodifiable Risk Factors, Comorbidities and Comedications With Ischemia/Reperfusion Injury and Cardioprotection by Pharmacological Treatments and Ischemic Conditioning (2022) (5)
Abstract 16909: Sarcoplasmic Reticulum Calcium Leak and Enhanced NCX Increase Occurrence of Delayed Afterdepolarisations in Atrial Myocytes from Patients with Chronic Atrial Fibrillation (2010) (5)
Abstract 14531: Activation of NLRP3 Inflammasome Promotes Atrial Fibrillation (2016) (5)
Voltage‐gated Na+ channels: novel players in fibroblast‐to‐myofibroblast transition with a potential role in atrial arrhythmogenesis? (2012) (5)
Automatic common mode electrode-amplifier impedance balance with SPLL synchronization (2016) (5)
The impact of Twitter promotion on future citation rates: The #TweetTheJournal study (2021) (5)
Atrial fibrillation in sub-Saharan Africa: The knowns and unknowns? (2019) (5)
Response to Letter Regarding Article, "Upregulation of K2P3.1 K+ Current Causes Action Potential Shortening in Patients With Chronic Atrial Fibrillation". (2016) (5)
Role of triggers and substrate in heart failure based atrial fibrillation: Is pulmonary vein isolation still the cornerstone of atrial fibrillation therapy? (2017) (4)
Assessment of OMT-28, a synthetic analog of omega-3 epoxyeicosanoids, in patients with persistent atrial fibrillation: Rationale and design of the PROMISE-AF phase II study (2020) (4)
New concepts in understanding and modulating atrial repolarisation in patients with atrial fibrillation (2008) (4)
Kv1.1 potassium channel subunit deficiency alters ventricular arrhythmia susceptibility, contractility, and repolarization (2021) (4)
The multiple proarrhythmic roles of cardiac calcium-handling abnormalities: triggered activity, conduction abnormalities, beat-to-beat variability, and adverse remodelling. (2016) (4)
Genetic inhibition of Nuclear Factor of Activated T-cell c2 (NFATc2) prevents atrial fibrillation in CREM transgenic mice. (2021) (4)
Repurposing traditional immunomodulators to target the inflammatory burden of atherosclerosis (2020) (4)
Atrial-Specific LKB1 Knockdown Represents a Novel Mouse Model of Atrial Cardiomyopathy With Spontaneous Atrial Fibrillation. (2021) (4)
Management of patients with newly-diagnosed atrial fibrillation: Insights from the BALKAN-AF survey (2019) (4)
Sleep apnea and atrial fibrillation: challenges in clinical and translational research (2022) (4)
Models of Human Atrial Action Potential for Sinus Rhythm and Chronic Atrial Fibrillation (2011) (4)
DPP10 is a new regulator of Nav1.5 channels in human heart. (2019) (4)
45 – The Molecular Pathophysiology of Atrial Fibrillation (2014) (4)
Abstract 12988: MicroRNA Changes and Atrial Arrhythmogenic Remodeling in Tachycardiomyopathic Heart Failure (2010) (4)
Erratum to: Differential regulation of protein phosphatase 1 (PP1) isoforms in human heart failure and atrial fibrillation (2017) (4)
Challenges and Opportunities in Improving the Management of Atrial Fibrillation: Recent Research Advances and their Clinical Translation. (2021) (3)
Left-ventricular innervation assessed by 123I-SPECT/CT is associated with cardiac events in inherited arrhythmia syndromes. (2020) (3)
Rate-adaptive pacing using intracardiac impedance shows no evidence for positive feedback during dobutamine stress test. (2002) (3)
PLK2 is a novel regulator of osteopontin-driven fibrosis and diastolic dysfunction in permanent atrial fibrillation (2020) (3)
Automatic current driven electrode-amplifier impedance balance with SPLL synchronization (2016) (3)
Pleiotropic actions of ticagrelor versus clopidogrel – Do molecular differences translate into superior clinical efficacy after myocardial infarction? (2020) (3)
Sleep apnea and atrial fibrillation: Update 2020 (2020) (3)
Rotors anchored by refractory islands drive Torsades de Pointes in an experimental model of electrical storm. (2021) (3)
Anticoagulation in difficult settings RELOADed: Evidence for applicability of direct oral anticoagulants in patients with atrial fibrillation, renal impairment and cancer (2019) (3)
Current Causes Action Potential Shortening in Patients with Chronic Atrial Fibrillation (2015) (3)
Role of abnormal sarcoplasmic reticulum function in atrial fibrillation. (2010) (3)
The biology of human pulmonary veins: does it help us to better understand AF pathophysiology in patients? (2013) (3)
Genome-wide association studies of atrial fibrillation: Finding meaning in the life of risk loci (2019) (3)
Postoperative Atrial Fibrillation: Features, Mechanisms, and Clinical Management. (2021) (3)
Unique cardiomyocyte ultrastructure in atria: Role of T tubules in subcellular Ca2+ signaling and atrial arrhythmogenesis. (2017) (3)
Rat engineered heart tissue: a novel tool in the safety pharmacology toolkit? (2014) (3)
039Enhanced Activation of Inflammasome Promotes Atrial Fibrillation (2017) (3)
Abstract 11919: AMP-Activated Protein Kinase Response to Metabolic Stress: A Novel Determinant of Atrial Fibrillation Progression (2014) (2)
Challenges to the translation of basic science findings to atrial fibrillation therapies. (2016) (2)
Direct oral anticoagulation and severe obesity – One size fits all? (2021) (2)
Nitric oxide as a fragile switch between cardioprotection and cardiac injury. (2021) (2)
Problem-based learning: a new pathway to competence? (2002) (2)
Erratum: "Revealing kinetics and state-dependent binding properties of IKur-targeting drugs that maximize atrial fibrillation selectivity" [Chaos 27, 093918 (2017)]. (2017) (2)
Abstract 14853: The Potential Role of Fibroblast Kv Channels in Atrial Fibrotic Profibrillatory Remodeling (2013) (2)
Abstract 2575: Mechanisms Underlying Activation of Constitutive Acetylcholine-regulated Potassium Channels by Atrial Tachycardia Remodeling (2009) (2)
[Cardiovascular pharmacotherapy. Risks and adverse effects]. (2014) (2)
Brief communication Decreased phosphorylation levels of cardiac myosin-binding protein-C in human and experimental heart failure (2007) (2)
Use of pulsed electron avalanche knife (PEAK) PlasmaBlade™ in patients undergoing implantation of subcutaneous implantable cardioverter-defibrillator (2019) (2)
Transcription factors for ion channels: active or passive players in cardiac remodeling? (2003) (2)
The gut microbial-derived metabolite trimethylamine N-oxide: A missing link between lifestyle-components and atrial fibrillation? (2020) (2)
Tools to Keep the Clock Ticking: Molecular Approaches to Treat Sinus Node Dysfunction (2015) (2)
Highlights from the International Journal of Cardiology Heart & Vasculature: Heart failure, atrial fibrillation, coronary artery disease and myocardial infarction (2019) (2)
High-Q Bandpass Comb Filter for Mains Interference Extraction (2009) (2)
Breaking bad: Higher risk of osteoporosis with vitamin K antagonists compared to direct oral anticoagulants in patients with atrial fibrillation (2020) (2)
TGF-β1–induced endothelial-mesenchymal transition: a potential contributor to fibrotic remodeling in atrial fibrillation? (2022) (2)
Do genetics help to better understand the underlying mechanisms of atrial fibrillation? (2006) (2)
New antiarrhythmic targets in atrial fibrillation. (2015) (2)
Gut-microbiota derived TMAO: A risk factor, a mediator or a bystander in the pathogenesis of atrial fibrillation? (2021) (2)
Assessment of responses to phenylephrine and prostaglandin F2 alpha by dorsal hand vein compliance technique Reproducibility and influence of vein diameter (2002) (2)
Abstract 5347: Alpha-Adrenergic-Regulation of IK1 and Acetylcholine-gated IK,ACh is Impaired in Patients with Atrial Fibrillation (2008) (2)
Potential antiarrhythmic actions of anticoagulants: Do they exist and can they be clinically unmasked? (2021) (2)
Facilitated electrical cardioversion: does the selection of the antiarrhythmic drug matter? (2019) (2)
Bayesian network analyses in atrial fibrillation – A path to better therapies?☆ (2019) (2)
5-hydroxytryptamine and atrial arrhythmogenesis: a "culprit mechanism" or bystander in patients with chronic atrial fibrillation? (2007) (2)
Smart device-based detection of atrial fibrillation: Opportunities and challenges in the emerging world of digital health. (2019) (2)
Effects of Modulation of Small-Conductance Calcium-Activated Potassium Current on Atrial Electrophysiology and Arrhythmogenesis: A Population-Based Computational Study (2018) (2)
Transformerless High-quality Electrocardiogram and Body Impedance Recording by an Amplifier with Current-Driven Inputs (2009) (1)
Stretching the limits of antiarrhythmic drug therapy: The promise of small-conductance calcium-activated potassium channel blockers (2021) (1)
One for all and all for one? The dilemma of optimal management of atrial fibrillation with cardiac co-morbidities. (2020) (1)
Abstract 13765: Repeated Paroxysmal Atrial Fibrillation Episodes Remodel Ionic Currents and Promote Atrial Fibrillation in Dogs (2013) (1)
Heart failure with preserved ejection fraction meets atrial fibrillation: is enhanced inflammasome signaling a major common mechanism leading to these two frequent diseases? (2020) (1)
Molecular determinants and therapeutic potential of focal ectopic activity: more than meets the Iti. (2022) (1)
Software Automatic Gain Control for Common Mode Interference Stabilization (2020) (1)
Abstract 14037: Angiotensin II Promotes Atrial Fibrillation in Mice by CaMKII Oxidation (2011) (1)
Abstract 13977: Mechanisms Underlying Delayed Afterdepolarisations and Triggered Activity in Human Atrial Fibrillation (2011) (1)
Abstract 13235: Enhanced Receptor-independent Nucleoside Diphosphate Kinase Mediated Gs Protein Signaling Contributes to Arrhythmogenic Calcium Mishandling in Atrial Fibrillation (2016) (1)
Atrial fibrillation in a dish: Insights into atrial arrhythmogenesis from induced pluripotent stem cell derived cardiomyocytes. (2019) (1)
In-depth characterization of a mouse model of postoperative atrial fibrillation (2022) (1)
Atrial Ca2+/calmodulin-dependent protein kinase II: A druggable master switch of atrial fibrillation-associated atrial remodeling? (2019) (1)
Abstract 17762: Temporal Evolution of Atrial Remodeling and Atrial Arrhythmogenesis During Tachycardiomyopathic Heart Failure Development (2010) (1)
Universitet Integrating new approaches to atrial fibrillation management the 6 th AFNET / EHRA Consensus Conference (2018) (1)
Soluble fibrin monomer complex as a candidate sentinel for adverse events in patients with heart failure (2021) (1)
Review of “Analysis and application of analog electronic circuits to biomedical instrumentation” by Robert B Northrop (2012) (1)
Phosphodiesterase 8 governs cAMP/PKA-dependent reduction of L-type calcium current in human atrial fibrillation: a novel arrhythmogenic mechanism. (2023) (1)
KCNQ1 autoantibodies: another way to regulate IKs. (2013) (1)
[New antiarrhythmic drugs for therapy of atrial fibrillation: I. Ion channel blockers]. (2006) (1)
Novel role of the protein phosphatase 1 regulatory subunit PPP1R3A in atrial fibrillation (2018) (1)
Electrical storm: mechanistic and therapeutic considerations to avoid death in the survivors. (2018) (1)
Surgery-related cardiac stress: A susceptibility test of late atrial fibrillation recurrence? (2020) (1)
Regulation of l-type Ca2+ channels in left atria of patients with chronic atrial fibrillation (2007) (1)
Obstructive respiratory events during procedural sedation and analgesia: Another WHY to routinely screen for sleep apnea before catheter ablation of atrial fibrillation (2021) (1)
Innovative Therapeutics for Atrial Fibrillation: Imminent Breakthroughs or Much Ado About Nothing? (2015) (1)
Oxidative stress: a bystander or a causal contributor to atrial remodelling and fibrillation? (2021) (1)
Stroke prevention of atrial fibrillation: Improving geographic under-use of contemporary antithrombotic approaches remains a challenge (2021) (1)
Abstract 12860: Enhanced Expression and PKCδ-mediated Hyperphosphorylation Underlie the Proarrhythmic Increase in Na+-Ca2+ Exchanger Activity in Patients With Chronic Atrial Fibrillation (2016) (1)
Recurrence of atrial fibrillation following non-cardiac surgery or acute illness: A common but rarely detected complication (2020) (1)
Sex‐specific density of ventricular SK currents: is this a general feature of SK channel function? (2018) (1)
Calcium-Dependent Regulation of Potassium Channels in Cardiac Electrophysiology: A Computational Study (2018) (1)
Targeting supraventricular ectopic complexes: Which approach should be used and how does it affect atrial fibrillation? (2017) (1)
Fibrillation Initiation , Maintenance , and Progression (2014) (1)
Electrocardiographic sex-related differences in patients with atrial fibrillation: Do they allow a better risk stratification? (2020) (1)
Recording Atrial Monophasic Action Potentials Using Standard Pacemaker Leads: (2004) (1)
[Molecular basis of remodelling in atrial fibrillation]. (2004) (1)
Prognostic impact of electrical storm in patients with implantable cardioverter defibrillators: Mechanistic and therapeutic considerations to reduce the risk of death. (2018) (1)
TRPC 3-Dependent Fibroblast Regulation in Atrial Fibrillation Running title : (2012) (1)
KCNQ 1 autoantibodies : another way to regulate I Ks (2013) (1)
The temporal context of oral anticoagulation outcome in atrial fibrillation (2022) (1)
Can cystatin C-based estimated glomerular filtration rate help to guide individualized risk factor modification programs? (2018) (1)
Genetic engineering of the first functional human cardiomyocyte lines for building clinically relevant atrial fibrillation models (2020) (1)
[New aspects of atrial fibrillation therapy]. (2006) (1)
Targeting atrial fibrillation promoting atrial structural remodeling: is this a viable strategy in patients with heart failure? (2018) (1)
Pro-arrhythmic RyR2 channels in heart failure: do their localisation and mechanism of activation really matter? (2018) (1)
The not-so-sweet problem of hearts aflutter: Dissecting stroke risk in atrial fibrillation with concomitant diabetes. (2018) (1)
Prevention of atrial fibrillation complications with antiarrhythmic drugs: still an unmet need in clinical practice (2011) (1)
Application of Active Biased Integrators for Biosignal Processing (2021) (1)
Diversity and functional roles of K + channels in cardiac repolarization : from single cell to whole organ levels (2016) (1)
A Lossy Integrator with Active Bias Point (2021) (1)
Presence of Left-to-Right Atrial Inward Rectifier Potassium Current Gradient in Patients with Paroxysmal but Not Chronic Atrial Fibrillation (2009) (0)
Recent highlights on myocarditis, cardiovascular complications of COVID-19, and cardiomyopathies from the International Journal of Cardiology: Heart & Vasculature (2022) (0)
receptors(RyR2s)ishypothesizedtocontributetoarrhythmogenesisinAF,butthemolecularmechanisms areincompletelyunderstood.Here,wehaveshownthatmicewithageneticgain-of-functiondefectinRyr2 (whichwetermedRyr2 R176Q/+ mice)didnotexhibitspontaneousAFbutthatrapidatrialpacingunmasked anincreasedvulnerabilitytoA (2009) (0)
Dynamic balance of platelet reactivity in atrial fibrillation PARtially unravelled. (2017) (0)
Abstract 12646: Cellular Mechanisms Underlying Post-operative Atrial Fibrillation in Patients (2016) (0)
Polypill revisited – Unity in diversity (2020) (0)
Common disease-promoting signaling pathways in heart failure and atrial fibrillation: putative underlying mechanisms and potential therapeutic consequences. (2022) (0)
Characterization of temporal electrical activity patterns for detection of critical isthmus regions of recurrent atypical atrial flutter. (2021) (0)
Abstract 1529: Chamber-specific Differences of IK,ACh Remodelling in Patients with Atrial Fibrillation (2008) (0)
Abstract 3848: Enhanced Myofilament Responsiveness Upon {beta}-Adrenergic Stimulation in Post-infarct Remodeled Myocardium Mediated by Increased Ca2+-Dependent Calmodulin Kinase II Activity (2009) (0)
Abstract 14534: Sarcoplasmic Reticulum Ca2+ Release via Ryanodine Receptor Type-2 Promotes Maintenance to Chronic Atrial Fibrillation (2012) (0)
Abstract 14767: Mechanism of Proarrhythmic Spontaneous Ca2+ Release Events in Patients With Paroxysmal Atrial Fibrillation (2013) (0)
Proteomics: A promising approach to discover new biomarkers for atrial fibrillation. (2021) (0)
Abstract 11940: Mineralocorticoid Receptor Dysregulation by MicroRNA-135a in Bradycardic Arrhythmogenic Remodeling (2014) (0)
Automatic Common Mode Electrode-Amplifier Impedance Balance: Implementation and Results (2019) (0)
myocardium with high-density oligonucleotide arrays Comparing the global mRNA expression profile of human atrial and ventricular (2013) (0)
Ca 2 (cid:1) -Related Signaling and Protein Phosphorylation Abnormalities Play Central Roles in a New Experimental Model of Electrical Storm phosphorylation mediators like cAMP-Received (2011) (0)
Abstract 17013: Transverse (T)-tubules Are Widespread in the Human Atrium (2011) (0)
Enhanced Sarcoplasmic Reticulum Ca 2 (cid:1) Leak and Increased -Ca Exchanger Function Underlie Delayed Afterdepolarizations in Patients With Chronic Atrial Fibrillation (2012) (0)
with mitral stenosis MicroRNA expression signature in atrial fibrillation (2015) (0)
Abstract 492: Molecular Determinants of Ca2+-Handling Abnormalities Underlying Contractile Dysfunction in Dilated versus Fibrillating Goat Atria (2007) (0)
The 825T-allele of the GNB3 gene is associated with higher basal inward rectifier current in human chronic atrial fibrillation (2005) (0)
Antiarrhythmic Drugs (2020) (0)
Abstract 13190: Integrin Linked Kinase is Required for Integrity of Cardiac Ion Current and Electrophysiologic Function (2014) (0)
Abstract 12665: Remodeling of Nuclear Ca2+ Disposition in Atrial Fibrillation Associated Remodeling (2015) (0)
A gut feeling - Lipopolysaccharide links gut dysbiosis with inflammatory atrial cardiomyopathy, obesity and atrial fibrillation. (2022) (0)
GW25-e5168 Impaired Post-Transcriptional Regulation of RyR2 by microRNA-106b-25 Cluster Promotes Atrial Fibrillation (2014) (0)
Pleiotropic actions of amiodarone: still puzzling after half a century (2013) (0)
The impact of an atrial septal defect on the progression of atrial tachypacing-induced atrial fibrillation in a Danish Landrace pig: A case report (2022) (0)
Adaptive Incremental Estimation Filter for AC Noise in the Electrocardiogram (2015) (0)
Computational Analysis of Heart-Failure-Related Remodeling of Cytosolic and Nuclear Calcium Handling in the Canine Atrial Cardiomyocyte (2016) (0)
Abstract 19806: Enhanced Intracellular Ca2+ Buffering Capacity Causes Failure of Intracellular Ca2+ Wave Propagation in Tachycardia-induced Atrial Remodeling (2010) (0)
Switching off the jitters: Dabigatran as a candidate approach to halt atrial fibrillation? (2018) (0)
Personalized management of sleep apnea in patients with atrial fibrillation: An interdisciplinary and translational challenge (2021) (0)
Oxidized CaMKII Triggers Atrial Fibrillation Running title : (2013) (0)
Myosin Light Chain Dephosphorylation by PPP1R12C Promotes Atrial Hypocontractility in Atrial Fibrillation (2020) (0)
Recent highlights on acute myocardial infarction and takotsubo syndrome from the International Journal of Cardiology: Heart & Vasculature (2022) (0)
Protective effects of piracetam on hypoxia-induced inhibition of veratridine-induced [14C]-DA outflow from rat striatum (1995) (0)
Clinical practice guidelines of the ESC on myocardial revascularization, 2014 (2015) (0)
Abstract 15870: Selective Nuclear CaMKII Activation and HDAC4 Export in Atrial Fibrillation (2017) (0)
Abstract 97: Ablation of Calpain-Targeted Site in Cardiac Myosin Binding Protein C Is Cardioprotective (2012) (0)
Molecular Determinants of Altered Ca 2 (cid:1) Handling in Human Chronic Atrial Fibrillation (2006) (0)
Abstract 252: Downregulated Striated Muscle Preferentially Expressed Protein Kinase Enhances Susceptibility to Post-Operative Atrial Fibrillation (2018) (0)
Minding the gap – Heterogeneity of antithrombotic treatment preferences in complex scenarios in absence of evidence-based guidelines (2021) (0)
Correlated Multiple Sampling Techniques for Sensor Signal Conditioning (2020) (0)
Persisting stroke risk in patients with atrial fibrillation despite proper anticoagulation - Unmet clinical needs. (2022) (0)
Abstract 2898: Compartment-Specific Alteration of Intracellular Ca2+ -Handling in Tachycardia-Induced Atrial Remodeling Assessed by Confocal Ca2+ Imaging (2009) (0)
Therapy-refractory AF: A clear unmet need for the development of novel antiarrhythmic drugs. (2021) (0)
Chronic loss of inhibitor-1 diminishes cardiac RyR2 phosphorylation despite exaggerated CaMKII activity (2017) (0)
Interference with ERK-dimerization at the nucleocytosolic interface targets pathological ERK1/2 signaling without cardiotoxic side-effects (2020) (0)
Sex-specific contribution of small-conductance Ca2+-activated K+ current to atrial electrophysiology and arrhythmogenesis. (2023) (0)
Resveratrol: an effective pharmacological agent to prevent inflammation-induced atrial fibrillation? (2018) (0)
AP19-00832 Abstract View (2019) (0)
Evolving insights into the pleiotropic cardioprotective mechanisms of SGLT2 inhibitors (2023) (0)
Targeting atrial fibrillation promoting atrial structural remodeling: is this a viable strategy in patients with heart failure? (2018) (0)
current modulates action potential rate dependence in patients with chronic atrial fibrillation (2013) (0)
Abstract 12575: Nucleoside Diphosphate Kinase C is a Novel Regulator of cAMP Levels and G{beta}{gamma} Signaling in Cardiomyocytes (2011) (0)
Abstract 16481: A Novel Synthetic Omega-3 Epoxyeicosanoid Analogue Modulates Ca2+ Handling and Exerts Anti-Arrhythmic Effects (2017) (0)
Muscarinic type-1 receptors regulate I K,ACh in human atrial cardiomyocytes and are upregulated in patients with chronic atrial fibrillation (2018) (0)
Phospholamban and troponin I phosphorylation in remodeled left atria from patients with sinus rhythm and chronic atrial fibrillation (2006) (0)
Explorer Palmitoylation and Membrane Association of the Stress Axis Regulated Insert ( STREX ) Controls BK Channel Regulation by Protein Kinase C (2012) (0)
signaling instability, consistent with an adaptive molecular and cellular response to atrial tachycardia. Tachycardia-induced silencing of subcellular Ca 2+ signaling in atrial myocytes (2014) (0)
Sunday, 18 July 2010 (2010) (0)
Role of catheter location on local impedance measurements and clinical outcome with the new direct sense technology in cardiac ablation procedures (2022) (0)
SYMPOSIUM - CARDIAC ION CHANNELS AND THEIR MACROMOLECULAR COMPLEXES: ELECTROPHYSIOLOGY AND BEYOND – ON BEHALF OF THE WORKING GROUP ON CARDIAC CELLULAR ELECTROPHYSIOLOGY557Determinants of altered atrial Na+-Ca2+ exchanger function in patients with chronic atrial fibrillation (2015) (0)
38 – Cholinergic and Constitutive Regulation of Atrial Potassium Channel (2014) (0)
Abstract 1347: Increased Sarcoplasmic Reticulum Calcium Leak In FKBP12.6 Mice Associated With Atrial Fibrillation (2007) (0)
Oral anticoagulation and therapy of atrial flutter: discontinuation of anticoagulation revisited. (2021) (0)
Dynamic regulation of IK,ACh by protein kinases in human atrial myocytes: Influence of chronic atrial fibrillation (2005) (0)
Abstract 3501: Calmodulin Kinase II Activation of Mutant Ryanodine Channels Promotes Ectopic Activity and Atrial Fibrillation (2008) (0)
Application of the RIMARC algorithm to a large data set of action potentials and clinical parameters for risk prediction of atrial fibrillation (2014) (0)
Stroke prevention versus bleeding risk of vitamin-K antagonists: a double-edged sword in patients with atrial fibrillation who require surgery. (2009) (0)
Basic Science (2019) (0)
Abstract 19028: Ablation of the Calpain-Targeted Site in Cardiac Myosin Binding Protein-C is Cardioprotective (2012) (0)
In-silico analysis of the dynamic regulation of cardiac electrophysiology by Kv11.1 ion-channel trafficking. (2023) (0)
G-Protein β3-Subunit Polymorphism and Atrial Fibrillation (2002) (0)
Electrocardiographic characteristics associated with atrial fibrillation - What do they tell us? (2018) (0)
Abstract 950: Direct Evidence for an Important Role of Agonist-independent Constitutive IK,ACh Channel Activity in Atrial Tachycardia Remodeling (2007) (0)
Ectopic expression of S28A-mutated Histone H3 modulates longevity, stress resistance and cardiac function in Drosophila (2018) (0)
Abstract 5325: Electrical Storm: Role of Protein Phosphorylation Abnormalities and Ca2+-Calmodulin Related Signaling (2008) (0)
Prognostic value of biomarkers of impaired metabolism in heart failure patients with reduced ejection fraction (2019) (0)
Botulinum toxin for prevention of post-operative atrial fibrillation (2023) (0)
A disproportional rise in the growing submission rate to International Journal of Cardiology Heart & Vasculature during the COVID‑19 pandemic (2021) (0)
A Modeling Framework for Investigating the Role of Human Atrial Fibroblast Calcium Signaling in Fibrogenesis (2021) (0)
In Silico Assessment of Atrial Fibrillation-Selectivity of I kur Inhibitors: Role of Variability in Disease-Associated Remodeling (2018) (0)
Integrative human atrial modeling unravels interactive PKA and CaMKII signaling as key determinant of atrial arrhythmogenesis (2022) (0)
Abstract 2899: CaMKII Phosphorylation of RyR2 is Required for Atrial Fibrillation Induction in Mice (2009) (0)
Childhood infection and modern malnutrition: Do childhood infections create an inflammatory foundation for atherosclerosis in adult life? (2021) (0)
112 Total IgG of patients positive for beta1‐adrenoceptor‐autoantibodies exerts beta1‐adrenoceptor‐mediated effects in rat cardiomyocytes (2003) (0)
Determinants and therapeutic potential of calcium handling abnormalities in atrial fibrillation: What can we learn from computer models? (2022) (0)
P678S-glutathiolation of cMyBP-C reduces its phosphorylation and contributes to impairment of cardiac myocyte contractile function (2014) (0)
Saturday, 17 July 2010 (2010) (0)
Pericardial adipose tissue: An emerging biomarker of atrial fibrillation? (2021) (0)
The anticoagulation dilemma and future treatment avenues in patients with breast cancer and atrial fibrillation. (2020) (0)
Enhanced Ca2+-Dependent SK-Channel Gating and Membrane Trafficking in Human Atrial Fibrillation (2023) (0)
CARDIOVASCULAR Teaching antiarrhythmic therapy and ECG in simulator-based interdisciplinary undergraduate medical education (2005) (0)
EHRA/HRS/APHRS/SOLAECE expert consensus on Atrial cardiomyopathies: De ﬁ nition, characterisation, and clinical implication $ , $$ Journal of Arrhythmia (2016) (0)
Edinburgh Research Explorer Palmitoylation and Membrane Association of the Stress Axis Regulated Insert (STREX) Controls BK Channel Regulation by Protein Kinase C (2012) (0)
[Changes in the heart rhythm studied by the PWC170 test following physical loading]. (1993) (0)
Abstract 2353: Molecular Mechanisms of Left Ventricular Function Deterioration Associated With Electrical Storm (2009) (0)
Targeting the RyR (Ryanodine Receptor) to Prevent Atrial Fibrillation. (2022) (0)
Contemporary plaque imaging for risk stratification of coronary artery disease: Are we getting there? (2020) (0)
Visualization of fibroblast activation using 68Ga-FAPI PET/CT after pulmonary vein isolation with pulsed field compared with cryoballoon ablation. (2023) (0)
Faculty Opinions recommendation of Adrenergic control of a constitutively active acetylcholine-regulated potassium current in canine atrial cardiomyocytes. (2007) (0)
Atrial fibrillation substrate development before, during and after cardiac surgery: Who is to blame for late post-operative atrial fibrillation? (2022) (0)
901 Post‐operative atrial fibrillation after coronary artery bypass grafting is predicted by enhanced mRNA levels of the L‐type Ca2+ channel alpha1C subunit (2003) (0)
PDE8 Mediates L-type Ca2+ Channels Dephosphorylation in Human Atrial Fibrillation (2019) (0)
Abstract 9723: Calcium Loading Induces a PKC Isoform Switch That Activates Constitutive Acetylcholine Regulated Potassium Current in Atrial Fibrillation-Related Remodeling (2011) (0)
CaMKII isoforms and calcineurin (2014) (0)
Age-dependent increase in c-Jun N-terminal kinase-2 activity: does this help to understand Ca2+-calmodulin-dependent protein-kinase II-mediated atrial arrhythmogenesis in human atrial fibrillation? (2018) (0)
Distinct atrial and ventricular microRNA changes in experimental heart failure (2012) (0)
Coronary clot composition after myocardial infarction: Thrombus age matters (2019) (0)
B-PO01-052 ATRIAL-SPECIFIC LKB1 KNOCKDOWN REPRESENTS A NOVEL MOUSE MODEL OF ATRIAL CARDIOMYOPATHY WITH SPONTANEOUS ATRIAL FIBRILLATION (2021) (0)
Recent highlights on thrombosis and hemostasis from the International Journal of Cardiology: Heart & Vasculature (2022) (0)
[A selective decrease in cytochrome P450 in the liver microsomes of male rats following phenobarbital and 3-methylcholanthrene induction and acute tetrachloromethane poisoning]. (1993) (0)
AP19-00047 Abstract View (2019) (0)
Assessment of atrial function by echocardiography: Can this be used to assess the arrhythmogenic atrial substrate? (2022) (0)
Increased FDG uptake in AF individuals suggesting atrial inflammation visualized by FDG PET/CT with glucose uptake suppression protocols (2021) (0)
Atrial Fibrillation Substrate in a Transgenic Mouse Model Mediated Calcium Leak Drives Progressive Development of an − Ryanodine Receptor (2014) (0)
Palmitoylation controls BK channel regulation by protein kinase C (2012) (0)
P4-6: Differential alteration of sarcoplasmic reticulum function in dilated versus fibrillating atria (2006) (0)
Diversity of Cells and Signals in the Cardiovascular System. (2023) (0)
The virtual patient – Estimating the health utility of aspirin in simulated populations (2021) (0)
Response to: "The emerging role of hybrid ablation for ablation" by Spartialis M. et al. (2017) (0)
f Two-electrode non-differential biopotential amplifier (0)
Implantable cardioverter-defibrillator therapy in primary versus secondary prevention: Reliable prediction of appropriate therapies and mortality is still an unmet need (2021) (0)
Role of Late Sodium Current in Experimental Torsade de Pointes (2018) (0)
Abstract 17175: Phoshodiesterase 2 - A New Member Of Proteins Involved In Beta-adrenergic Desensitization (2013) (0)
Erratum: (Biophysical Journal) (2011) (0)
Researchers in cardiology – Why and how to get on Twitter? (2022) (0)
Abstract 16396: Atrial Fibrillation Upregulation of Nucleoside Diphosphate Kinase, Induces Proarrhythmic Sarcoplasmic Reticulum Ca 2+ Leak in Canine Atria (2017) (0)
Outcome of atrial fibrillation ablation in pulmonary hypertension: Is pulmonary hypertension a modifiable risk factor? (2019) (0)
Chronic Total occlusion of infarct-related artery: A bystander or a risk factor of electrical storm? (2022) (0)
Comments on “An Analog Bootstrapped Biosignal Read-Out Circuit With Common-Mode Impedance Two-Electrode Compensation” (2021) (0)
Fat chance for POAF? Pericardial adipose tissue and the arrhythmogenic substrate for postoperative atrial fibrillation (2022) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Dobromir Petkov Dobrev?

Dobromir Petkov Dobrev is affiliated with the following schools: